PanGraf 1.0 Tacrolimus Capsules 1.0 mg

Pharma

PanGraf 1.0 Tacrolimus Capsules 1.0 mg

Immunosuppressant agent; 1.0 mg Tacrolimus capsules for transplant rejection prevention.

Warranty
30-Day Returns
Secure Checkout

PanGraf 1.0 Tacrolimus Capsules 1.0 mg

PanGraf 1.0 contains 1.0 mg of Tacrolimus, a potent immunosuppressant and calcineurin inhibitor. It is primarily used to prevent organ rejection in patients who have received kidney, liver, or heart transplants. It works by suppressing the body's immune system to stop it from attacking the new organ. Due to its potency, precise dosing and regular blood tests to monitor drug concentration levels are critical. Patients should be aware of side effects such as tremors, kidney function impairment, and an increased susceptibility to infections. It should be taken consistently at the same time each day.

You May Also Like

Treviamet (Sitagliptin + Metformin HCl Tablets)
Treviamet (Sitagliptin + Metformin HCl Tablets)

Combination DPP-4 inhibitor and Biguanide; 50 mg/500 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.

Treviamet (Sitagliptin + Metformin HCl Tablets)
Treviamet (Sitagliptin + Metformin HCl Tablets)

Combination DPP-4 inhibitor and Biguanide; 50 mg/1000 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.

Galvus Met (Vildagliptin/Metformin HCl 50 mg/500 mg)
Galvus Met (Vildagliptin/Metformin HCl 50 mg/500 mg)

Combination DPP-4 inhibitor and Biguanide; 50mg/500mg Vildagliptin/Metformin tablets for Type 2 Diabetes control.

Dapefy SM (Dapagliflozin, Sitagliptin and Metformin ER Tablets)
Dapefy SM (Dapagliflozin, Sitagliptin and Metformin ER Tablets)

Triple antidiabetic combo; Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin ER 1000 mg (28 tablets) for Type 2 Diabetes.